Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Zhu, Min

Class:IdPerson:9024871
_displayNameZhu, Min
_timestamp2017-10-10 12:10:26
created[InstanceEdit:9024874] Jassal, Bijay, 2017-10-10
firstnameMin
initialM
surnameZhu
(author)[LiteratureReference:9024882] Novel proresolving aspirin-triggered DHA pathway
[LiteratureReference:9024980] The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype
[LiteratureReference:9024984] Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain
[LiteratureReference:9662009] Molecular mechanisms of missense mutations that generate ectopic N-glycosylation sites in coagulation factor VIII
[LiteratureReference:9662022] Missense mutations near the N-glycosylation site of the A2 domain lead to various intracellular trafficking defects in coagulation factor VIII
[LiteratureReference:9932774] Super-enhancers and the super-enhancer reader BRD4: tumorigenic factors and therapeutic targets
[Change default viewing format]
No pathways have been reviewed or authored by Zhu, Min (9024871)